da Silveira Gerzson Alexandre, Machado Denise Cantarelli, Marinovic Daniel Rodrigo, Pagnoncelli Rogério Miranda
Int J Oral Maxillofac Implants. 2017 May/Jun;32(3):e183-e189. doi: 10.11607/jomi.5326.
Biomaterials, as an alternative to autogenous bone and other biologic tissues, have been widely used in oral and maxillofacial surgery. In this context, a biomaterial that functions as a scaffold (osteoconductor), combined with a growth factor (osteoinductor), would be of great interest for clinical application. Biodegradable polymers used for slow drug release have been investigated, demonstrating good results and interesting potential. Growth hormone (GH) may be released by incorporating it into these polymers. This study aimed to evaluate cell adhesion and proliferation of a polymeric biomaterial for slow release of recombinant human GH (rhGH).
Poly(lactic-co-glycolic acid) (PLGA) and PLGA/polycaprolactone (PCL) (at a 70/30 ratio of PLGA to PCL) matrices were prepared by the solvent evaporation method, combined or not with GH. Biomaterials were tested for cell adhesion and proliferation by culture in mesenchymal stem cells derived from Wistar rat bone marrow, 4',6-diamidino-2-phenylindole (DAPI) staining, and subsequent cell counting, in addition to scanning electron microscopy. Cell adhesion and proliferation was assessed at 24 and 72 hours of biomaterial exposure to culture medium.
All tested polymers exhibited cell adhesion and proliferation. However, PLGA-based biomaterials, especially when combined with GH, showed greater cell proliferation when the difference in growth from 24 to 72 hours was evaluated. GH appeared to modify the polymer surface, with increased roughness and microporosity. This feature was more evident in the PLGA + GH combination.
The biomaterials tested showed pronounced cell adhesion in all test groups, and GH appeared to contribute to the increase in cell proliferation, especially when combined with PLGA as compared with pure PLGA. Further studies are required to clarify this potential for development of new biomaterials.
生物材料作为自体骨和其他生物组织的替代品,已在口腔颌面外科中广泛应用。在这种情况下,一种作为支架(骨传导材料)并结合生长因子(骨诱导材料)的生物材料将在临床应用中具有极大的吸引力。用于药物缓释的可生物降解聚合物已得到研究,显示出良好的效果和有趣的潜力。生长激素(GH)可通过将其掺入这些聚合物中来实现释放。本研究旨在评估用于重组人生长激素(rhGH)缓释的聚合物生物材料的细胞黏附及增殖情况。
采用溶剂蒸发法制备聚乳酸-乙醇酸共聚物(PLGA)以及PLGA/聚己内酯(PCL)(PLGA与PCL比例为70/30)基质,分别与GH结合或不结合。通过在源自Wistar大鼠骨髓的间充质干细胞中培养、4',6-二脒基-2-苯基吲哚(DAPI)染色及后续细胞计数,以及扫描电子显微镜,对生物材料进行细胞黏附及增殖测试。在生物材料暴露于培养基24小时和72小时时评估细胞黏附及增殖情况。
所有测试的聚合物均表现出细胞黏附及增殖。然而,基于PLGA的生物材料,尤其是与GH结合时,在评估24小时至72小时的生长差异时显示出更大的细胞增殖。GH似乎改变了聚合物表面,使其粗糙度和微孔率增加。这一特征在PLGA + GH组合中更为明显。
所测试的生物材料在所有测试组中均表现出明显的细胞黏附,并且GH似乎有助于细胞增殖的增加,特别是与纯PLGA相比,与PLGA结合时。需要进一步研究以阐明这种用于开发新型生物材料的潜力。